Related search

Targeting Tumour Microenvironment by Tyrosine Kinase Inhibitor

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

Aurora Kinase a (AURKA; Aurora-A)

Science-Business eXchange
2012English

Selection of Cyclic-Peptide Inhibitors Targeting Aurora Kinase A: Problems and Solutions

Bioorganic and Medicinal Chemistry
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2011English

VHL Loss Predicts Response to Aurora Kinase a Inhibitor in Renal Cell Carcinoma Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

Aurora Kinase a Promotes Inflammation and Tumorigenesis in Mice and Human Gastric Neoplasia

Gastroenterology
HepatologyGastroenterology
2013English

Clinical Benefit to an Aurora a Kinase Inhibitor in a Patient With Metastatic Integrase Interactor 1‐Deficient Carcinoma

Oncologist
Cancer ResearchMedicineOncology
2018English

A Phase I Study of BI 811283, an Aurora B Kinase Inhibitor, in Patients With Advanced Solid Tumors

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2016English

TOPK Inhibitor HI-TOP-32 Administration in DEN-induced Hepatocarcinogenesis in C57bl/6 Mice Results in Tumour Regression

HPB
HepatologyGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy